Cargando…
Intranasal Administration of KYCCSRK Peptide Rescues Brain Insulin Signaling Activation and Reduces Alzheimer’s Disease-like Neuropathology in a Mouse Model for Down Syndrome
Down syndrome (DS) is the most frequent genetic cause of intellectual disability and is strongly associated with Alzheimer’s disease (AD). Brain insulin resistance greatly contributes to AD development in the general population and previous studies from our group showed an early accumulation of insu...
Autores principales: | Tramutola, Antonella, Lanzillotta, Simona, Aceto, Giuseppe, Pagnotta, Sara, Ruffolo, Gabriele, Cifelli, Pierangelo, Marini, Federico, Ripoli, Cristian, Palma, Eleonora, Grassi, Claudio, Di Domenico, Fabio, Perluigi, Marzia, Barone, Eugenio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854894/ https://www.ncbi.nlm.nih.gov/pubmed/36670973 http://dx.doi.org/10.3390/antiox12010111 |
Ejemplares similares
-
The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome
por: Zuliani, Ilaria, et al.
Publicado: (2020) -
The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia
por: Perluigi, Marzia, et al.
Publicado: (2020) -
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
por: Tramutola, Antonella, et al.
Publicado: (2018) -
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome
por: Di Domenico, Fabio, et al.
Publicado: (2019) -
Proteomics Study of Peripheral Blood Mononuclear Cells in Down Syndrome Children
por: Lanzillotta, Chiara, et al.
Publicado: (2020)